Drug intelligence / Profile preview

Ialuxid

Development stage
Unknown
Lead developer
BMG Pharma
Modality
Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical, Intravaginal
01

Overview

Ialuxid is a consumer health topical gel marketed by Gynial, primarily composed of hydrogen peroxide, hyaluronic acid (sodium hyaluronate), and glycine. It is designed for the treatment of skin and mucosal infections, including those in the genital and vaginal areas. Hydrogen peroxide acts as a broad-spectrum oxidizing antiseptic that eliminates bacteria, fungi, and viruses by inducing oxidative stress. Hyaluronic acid serves as a humectant and biological signaling molecule that promotes tissue regeneration and maintains mucosal moisture, while glycine supports the structural integrity of the skin and mucosa during the healing process. In the context of Gynial's portfolio, it is utilized for managing localized skin or mucosal conditions such as folliculitis, impetigo, or molluscum contagiosum in the genital region.

Brand names
Ialuxid
Other names
Ialuxid Gel
02

Targets

CD44 (CD44 antigen)ICAM1 (Intercellular Adhesion Molecule 1)RHAMM (Hyaluronan-mediated motility receptor)

Beyond the preview

Go deeper on Ialuxid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ialuxid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call